IL-25 or IL-17E Protects against High-Fat Diet-Induced Hepatic Steatosis in Mice Dependent upon IL-13 Activation of STAT6.
about
Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease PathogenesisIL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity.Parasites, nutrition, immune responses and biology of metabolic tissues.
P2860
IL-25 or IL-17E Protects against High-Fat Diet-Induced Hepatic Steatosis in Mice Dependent upon IL-13 Activation of STAT6.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
IL-25 or IL-17E Protects again ...... pon IL-13 Activation of STAT6.
@ast
IL-25 or IL-17E Protects again ...... pon IL-13 Activation of STAT6.
@en
type
label
IL-25 or IL-17E Protects again ...... pon IL-13 Activation of STAT6.
@ast
IL-25 or IL-17E Protects again ...... pon IL-13 Activation of STAT6.
@en
prefLabel
IL-25 or IL-17E Protects again ...... pon IL-13 Activation of STAT6.
@ast
IL-25 or IL-17E Protects again ...... pon IL-13 Activation of STAT6.
@en
P2093
P2860
P50
P356
P1476
IL-25 or IL-17E Protects again ...... upon IL-13 Activation of STAT6
@en
P2093
Aiping Zhao
Allen Smith
An-Jiang Wang
Hongbing Wang
Nonghua Lu
Terez Shea-Donohue
Thirumalai R Ramalingam
Thomas A Wynn
Viktoriya Grinchuk
P2860
P304
P356
10.4049/JIMMUNOL.1500337
P407
P577
2015-09-30T00:00:00Z